Sign in

CIK 0001178253 · Non-accelerated filer<br>Smaller reporting company

SCYNEXIS INC

Sign in to watch
Ticker
SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
562181648
Phone
201-884-5485
Business address
1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
  1. 4 Grant or award Chief Executive Officer acquired 23,000 shares (grant or award)
  2. 4 Grant or award Chief Executive Officer acquired 18,800 shares (grant or award)
  3. 4 Grant or award Chief Legal Officer acquired 92,511 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 92,511 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 262,927 shares (grant or award)
  6. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.37 ($27,400)
  7. 4 Grant or award Director acquired 23,000 shares (grant or award)
  8. 4 Grant or award Director acquired 23,000 shares (grant or award)
  9. 4 Grant or award Director acquired 23,000 shares (grant or award)
  10. 4 Grant or award Director acquired 23,000 shares (grant or award)
  11. 4 Grant or award Director acquired 23,000 shares (grant or award)
  12. 4 Grant or award Director acquired 23,000 shares (grant or award)
  13. 4 Shares withheld for taxes Chief Legal Officer gave up 15,179 shares (to pay taxes)
  14. 4 Grant or award Chief Executive Officer acquired 290,590 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 143,675 shares (grant or award)
  16. 4 Grant or award Chief Legal Officer acquired 143,675 shares (grant or award)
  17. 4 Grant or award Director acquired 10,000 shares (grant or award)
  18. 4 Grant or award Director acquired 10,000 shares (grant or award)
  19. 4 Grant or award Director acquired 10,000 shares (grant or award)
  20. 4 Grant or award Director acquired 10,000 shares (grant or award)

Page 2 of 16 · 314 filings